Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-25-243708
Filing Date
2025-10-20
Accepted
2025-10-20 16:56:03
Documents
15
Effectiveness Date
2025-10-20

Document Format Files

Seq Description Document Type Size
1 S-8 d40313ds8.htm S-8 39897
2 EX-5.1 d40313dex51.htm EX-5.1 6619
3 EX-23.1 d40313dex231.htm EX-23.1 1573
4 EX-FILING FEES d40313dexfilingfees.htm   iXBRL EX-FILING FEES 12334
5 GRAPHIC g40313dsp8.jpg GRAPHIC 12479
  Complete submission text file 0001193125-25-243708.txt   197069

Data Files

Seq Description Document Type Size
17 EXTRACTED XBRL INSTANCE DOCUMENT d40313dexfilingfees_htm.xml XML 4706
Mailing Address 12278 SCRIPPS SUMMIT DRIVE SAN DIEGO CA 92131
Business Address 12278 SCRIPPS SUMMIT DRIVE SAN DIEGO CA 92131 858.875.1803
FATE THERAPEUTICS INC (Filer) CIK: 0001434316 (see all company filings)

EIN.: 651311552 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-290972 | Film No.: 251404464
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)